| 2024-06-11 | Sale | Y-mAbs Therapeutics, Inc. YMAB | CHIEF BUSINESS OFFICER | 35,000 0.0797% | $12.00 | $420,000 | -0.08% | |
| 2024-06-10 | Sale | Y-mAbs Therapeutics, Inc. YMAB | CHIEF BUSINESS OFFICER | 35,000 0.0795% | $12.03 | $421,050 | -0.54% | |
| 2024-05-23 | Sale | Y-mAbs Therapeutics, Inc. YMAB | CHIEF BUSINESS OFFICER | 7,351 0.0176% | $13.00 | $95,563 | -2.74% | |
| 2024-05-21 | Sale | Y-mAbs Therapeutics, Inc. YMAB | CHIEF BUSINESS OFFICER | 25,000 0.0544% | $12.00 | $300,000 | -3.9% | |
| 2024-03-05 | Sale | Y-mAbs Therapeutics, Inc. YMAB | CHIEF BUSINESS OFFICER | 3,900 0.0088% | $16.44 | $64,116 | -13.1% | |
| 2023-12-15 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Business Officer | 50,000 0.1144% | $6.61 | $330,500 | +98.95% | |
| 2023-12-14 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Business Officer | 50,000 0.113% | $6.83 | $341,500 | +91.25% | |
| 2023-12-13 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Business Officer | 50,000 0.1109% | $6.58 | $329,000 | +90.95% | |
| 2023-11-21 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Business Officer | 75,000 0.1721% | $5.31 | $397,988 | +137.24% | |
| 2023-11-20 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Business Officer | 75,000 0.1735% | $5.30 | $397,395 | +137.07% | |
| 2022-02-09 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 64,276 0.1455% | $6.96 | $447,117 | +59.6% | |
| 2022-02-08 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 125,863 0.2919% | $7.01 | $882,891 | +62.14% | |
| 2022-02-07 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 91,031 0.2111% | $7.59 | $691,180 | +49.8% | |
| 2022-02-04 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 101,104 0.2313% | $7.70 | $778,531 | +47.53% | |
| 2022-02-03 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 35,060 0.0801% | $7.90 | $277,027 | +41.85% | |
| 2022-02-01 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 8,000 0.0186% | $10.15 | $81,161 | +12.2% | |
| 2022-01-24 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 88,055 0.1949% | $10.63 | $936,412 | +2.09% | |
| 2022-01-21 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 70,318 0.1692% | $10.75 | $755,815 | +11.15% | |
| 2022-01-20 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 112,767 0.2659% | $11.33 | $1.28M | +2.09% | |
| 2022-01-19 | Sale | Y-mAbs Therapeutics, Inc. YMAB | See remarks | 69,414 0.1632% | $10.89 | $756,092 | +5.85% |